Back

Tricia Carrigan

Advisor

Experience

Global Precision Medicine team builder with an emphasis on transforming concepts into personalized diagnostic products. Advanced development, regulatory approval, and commercialization of biomarker in vitro diagnostic assays and Artificial Intelligence Software Algorithms (SaMD)  in  Oncology, Neuroscience, Cardiovascular, and Women’s Health.

Previous Companies

Merck (AVP, Companion Diagnostic Oncology), Bayer (Global Regulatory Head- Companion Diagnostics, Oncology, Women’s Health, and Cardiovascular), and Roche Ventana.

© 2024 General Inception. All rights reserved.

© 2024 General Inception. All rights reserved.

© 2024 General Inception. All rights reserved.